BIO.News Newsletter

We all know COVID-19 is exacerbating racial disparities in the United States. But why? We take a deep dive, plus give you more industry and D.C. news you need to know, in around 740 words, 3 minutes, 40 seconds.

Election Day is officially two weeks away. If you still need to figure out a voting plan or read up on the candidates in your state races, visit Biotech Votes. Today, we catch up on the latest COVID-19 vaccine news and get insights on the future of CRISPR, in 685 words, or 3 minutes, 30 seconds.

We’re starting a new week with an inspiring podcast episode featuring a biotech company working to combat climate change and racial injustice—and also produce innovative therapies. We have details, plus a closer look at Twist Bioscience’s announcement about a new partnership to expedite CAR T cancer treatments, in around 880 words, 4 and a half minutes.

BREAKING NEWS: The Wall Street Journal reports that Pfizer could apply for emergency use of a COVID-19 vaccine by late November. Pfizer CEO Albert Bourla published an open letter to speak directly to the public about the company's plans.In other news, the FDA approved the first drug to treat Ebola virus, which is a major breakthrough as Ebola continues to spread. We have details, plus what former VP Joe Biden said about carbon capture and renewable energy, in around 770 words, just under 4…

Day 2 of BIO Investor Forum Digital brought insights into how the FDA is handling the pandemic, the outlook for biotech markets and drug pricing policy, and practical advice on how to improve diversity and inclusion. As usual, Washington news at the end. Here are around 1,000 words, 5 minutes.

We recap a fantastic first day of BIO Investor Forum Digital, with a look at VC investment trends, the latest news from the AMR Action Fund, and why diversity matters in clinical trials and in companies. It's all below, plus your usual news from Washington, in just under 1,000 words, just under 5 minutes.

BIO Investor Forum Digital begins today—and we give you a sneak peek at what you’ll hear from both investors and emerging companies, as well as tell you how to follow along. We also take a closer look at COVID-19 and the world’s plastic problem and what’s happening in Washington. Here are around 785 words, just under 4 minutes.

BIO Investor Forum Digital kicks off tomorrow—and to get ready, Dr. Michelle talks to a biotech investor about everything from COVID-19 therapeutics and diagnostics to the impact of drug pricing policy on investors’ decision-making. Also, POET explains how biofuels can help farmers and the environment. Here are around 840 words, just over 4 minutes.

There’s been a lot of chatter about breakthrough coronavirus treatments this week—so today, we tell you how novel therapies come about in the United States. (No, it’s not magic.) And since we’re still excited about the Nobel Prize for Chemistry, we take a look at CRISPR’s potential in industrial biotech and biofuels. Here are 830 words, 4 minutes.

Today, we dig into the SCOTUS case addressing pharmacy benefit managers, and explain why we need to fix this system. Also, meet the winners of the Nobel Prize in Chemistry and learn why their technology is so important to human, animal, and environmental health. Here’s your Thursday news in 900 words, 4 and a half minutes.